Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03958656
Title T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

multiple myeloma

Therapies

Anti-SLAMF7 CAR T cells + Cyclophosphamide + Fludarabine

Rimiducid

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.